SP
BSX icon

Saranac Partners’s Boston Scientific BSX Stock Holding History

Saranac Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.42M Buy
150,265
+54,724
+57% +$2.97M 1.87% 24
2026
Q1 		$6.2M Buy
95,541
+18,895
+25% +$1.51M 2.65% 13
2025
Q4 		$7.31M Buy
76,646
+15,629
+26% +$1.53M 2.86% 14
2025
Q3 		$5.95M Buy
61,017
+5,033
+9% +$521K 1.08% 23
2025
Q2 		$6.01M Sell
55,984
-1,425
-2% -$144K 3.19% 9
2025
Q1 		$5.79M Buy
57,409
+3,929
+7% +$396K 3.29% 11
2024
Q4 		$4.78M Sell
53,480
-2,412
-4% -$212K 2.64% 16
2024
Q3 		$4.68M Sell
55,892
-4,275
-7% -$337K 7.07% 10
2024
Q2 		$4.63M Sell
60,167
-6,646
-10% -$486K 2.75% 17
2024
Q1 		$4.58M Sell
66,813
-7,897
-11% -$508K 2.8% 17
2023
Q4 		$4.32M Buy
+74,710
New +$3.99M 2.85% 13

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Saranac Partners's BSX Position: Q2 2026 in Review

Saranac Partners increased its Boston Scientific (BSX) stake by 57% in Q2 2026, buying an estimated $2.97M and bringing the position to 150,265 shares worth $6.42M. The position accounts for 1.87% of the portfolio, ranked #24.

Saranac Partners first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.31M in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Saranac Partners held 150,265 shares of Boston Scientific worth $6.42M as of Q2 2026.
  • Saranac Partners bought 54,724 Boston Scientific shares in Q2 2026, an estimated $2.97M.
  • Boston Scientific made up 1.87% of Saranac Partners's portfolio in Q2 2026, its #24 holding.
  • Saranac Partners first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Saranac Partners's Boston Scientific position peaked at $7.31M in Q4 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Saranac Partners's 13F filing for Q2 2026, filed 13 Aug 2026.